All lobbying filings

J M BURKMAN & ASSOCIATES

Lobbying for APARTES PHARMACEUTICALS · A leading North American pharma company with innovative new products.

Filing · LD-1 registration Registration

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted May 27, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Ontario

Official filing document

Conviction disclosures 2

A registrant must disclose criminal convictions of the lobbyists it lists, under the Honest Leadership and Open Government Act. This is the filer's own wording.

JACK MACAULEY BURKMAN 2022

Illegal campaign robo calls, telecommunications fraud. Cuyahoga County, Ohio. Offense took place in September 2020. Section 2913.05 Ohio code
JACOB WOHL 2022

Illegal campaign robo calls, telecommunications fraud. Cuyahoga County, Ohio. Offense took place in September 2020. Section 2913.05 Ohio code

Lobbying activity 1

Health Issues

Issues at HHS and FDA. Also. federal contracting issues. DOD contracting.

Foreign interests disclosed 1

Section 7 of the LD-2: foreign entities that own part of the client, paid toward this lobbying, or stand to benefit from it.

APARTES PHARMACEUTICALS

Canada · Toronto, Ontario · owns 100% of the client · contributed $0

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.